F 0745
Provide medically-related social services to help each resident achieve the highest possible quality of life.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, and record review, the facility failed to ensure interdisciplinary team (IDT, a group of health care
professionals with various areas of expertise who work together toward the goals to their residents)
quarterly care conference meeting arranged, conducted, and documented for two out of two sampled
residents (Resident 1and 2). This failure had the potential for Resident/resident responsible party (RP:
healthcare or financial decision maker for resident) to participate in the development and implement of
person-centered plan of care decisions for Resident 1 and 2.
Residents Affected - Few
Findings:
Review of Resident 1's face sheet (FS: a document that gives a resident's information at a quick glance)
indicated Resident 1 was admitted on [DATE]. Resident 1's FS also indicated Resident 1 was
self-responsible for daily decision making.
Review of Resident 1's custom IDT care conference forms indicated there was no documented evidence for
quarterly IDT care conference was arranged, conducted, and documented for 6/2023, 12/2023, and 7/2024
for 3 quarters.
Review of Resident 2's FS indicated Resident 2 was admitted to facility on 10/11/2023. Resident 2's FS
also indicated Resident 2's significant family member was assigned as Resident 2's RP.
Review of Resident 2's clinical documentation indicated there was no documented evidence for custom IDT
care conference was arranged, conducted, and documented after Resident 2 admitted to facility on
10/11/2023 for 3 quarters in a row.
During an interview with facility's director of nursing (DON) on 8/14/2024 at 12:10 p.m., DON confirmed
quarterly IDT care plan meeting and documentation was not completed for Resident 1 and 2 on quarterly
basis. DON stated facility's social service director (SSD) was responsible to arrange, conduct, and
document IDT care conferences every quarter, and as needed all residents.
During an interview with facility's SSD on 8/14/2024 at 12:43 p.m., SSD confirmed social service
department was responsible to arrange, conduct and document for quarterly care conferences for
residents. SSD also acknowledged facility was non-complainant with quarterly care conferences and
documentation for residents. SSD stated she identified this concern, auditing for all residents and she will
submit the audit report to quality assurance and performance improvement program (QAPI: data driven,
proactive approach to improving the quality of life, care, and services for residents). SSD also stated social
service staff should have arranged quarterly care plan meeting, documented every
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
055356
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055356
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oceanview Post Acute
200 Lighthouse Avenue
Pacific Grove, CA 93950
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0745
quarter, and as needed for all residents in the facility.
Level of Harm - Minimal harm
or potential for actual harm
During an interview with DON on 8/14/2024 at 12:55 p.m., DON stated SSD should have arranged
quarterly IDT care conference with resident/RP and documented for all residents.
Residents Affected - Few
Review of the facility's policy and procedure (P&P) titled, Care Planning-Interdisciplinary Team, revised
September 2013, the P&P indicated, Every effort will be made to schedule care plan meetings at the best
time of the day for the resident and family. The mechanics of how the Interdisciplinary Team meets its
responsibilities in the development of the interdisciplinary care plan (e.g., face-to-face, teleconference,
written communication, etc.) is at the discretion of the Care Planning Committee.
Review of the facility's P&P titled, Social Worker, revised October 2020, the P&P indicated, Involve the
resident/family in planning individualized objectives and goals for the resident.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055356
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055356
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oceanview Post Acute
200 Lighthouse Avenue
Pacific Grove, CA 93950
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on an
observation, interview and record review, the facility failed to ensure medications were administered as
ordered by the medical doctor (MD) for 2 of 2 sampled Residents (Resident 1and 2). This failure had the
potential to adversely affects the health and well- being of Resident 1 and 2.
Findings:
A Record review of Resident 1's face sheet (FS: a document that gives a resident's information at a quick
glance) indicated Resident 1 was admitted to the facility on [DATE]. Review of Resident 1's FS indicated
Resident was admitted with diagnoses included dementia (loss of ability to think, remember, and reason to
levels that affect daily life and activities), and anxiety (persistent and excessive worry and fear about active
daily living situations).
Review of Resident 1's physician's medication orders indicated quetiapine (antipsychotic medication to
treat mental illness) 25 mg (mg: milligrams, unit of measurement of mass equal to a thousandth of a gram)
0.5 tablet one time a day, and before lunch for dementia ordered on 6/11/2024.
Review of Resident 1's electronic medication administration record (EMAR: a legal document for
medication administration record) for July 2024 indicated on 7/2, 7/3, 7/4, 7/7, 7/8, 7/9, 7/13, 7/14, 7/15,
7/18, 7/20, 7/21, 7/22, 7/25, 7/26, 7/27, 7/28, and 7/31, total 19 of 31 doses of quetiapine administration
documented as 9 (EMAR chart codes for 9= Other/See Progress Notes) at 11:30 a.m., and on 7/1, 7/9,
7/13, 7/16, 7/17, 7/20, 7/23, and 7/24, total 8 doses documented as 9 for quetiapine administration at 9:00
p.m.
During the record review of Resident 2's FS indicated Resident 2 was admitted to facility on 8/7/2024.
Review of Resident 2's FS indicated she was admitted with diagnoses included diabetes type 2 (a condition
when body unable to regulates and uses sugar as a fuel), hypertension (a condition in which the force of
the blood against the blood vessels wall), and atrial fibrillation (an irregular, often rapid heart rate that
commonly causes poor blood flow).
Review of Resident 2's documentation for brief interview for mental status (BIMS) dated 8/12/2024
indicated Resident 2's BIMS score of 15 of 15 (score of 0-7: severe impaired cognition, 8-12: moderately
impaired cognition, 13-15: intact cognition).
Review of Resident 2's physician medication orders indicated potassium chloride (used to treat
hypertension) ER 10 meq (milliequivalent: a unit of measurement used to express the amount of substance
in a solution) one time a day, ordered on 8/7/2024. Medication tizepatide (to treat diabetes type 2) 2.5
mg/0.5 ml (milliliter: a unit of volume that measures the capacity of a liquid) inject subcutaneously (insertion
of medication just under the skin) one time a day every 7 days ordered on 8/7/2024. Medication
rosuvastatin (used to treat to lower cholesterol [fat like substance in the blood]) 10 mg one time a day,
ordered on 8/8/2024.
Review of Resident 2's EMAR for August 2024 indicated medication rosuvastatin 10 mg administered on
8/8, 8/9, 8/10, 8/11, 8/12, and 8/13 at 9:00 p.m., total 6 doses administered to Resident 2. Further review of
EMAR documented as 9 for tirzepatide administration on 8/8/2024 at 9:00 a.m., and potassium chloride 20
meq medication administration documented at 9:00 a.m., as 9 on 8/8, 8/9, 8/10, 8/11,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055356
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055356
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oceanview Post Acute
200 Lighthouse Avenue
Pacific Grove, CA 93950
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
8/12, 8/13, and 8/14, total 7 doses.
Level of Harm - Minimal harm
or potential for actual harm
During an interview with Resident 2 on 8/14/2024 at 11:22 a.m., Resident 2 stated she did not receive
cholesterol medication 2 nights in row. Resident 2 also stated did not receive potassium and injection for
diabetes since admitted to facility. Resident 2 also stated Resident 2 was told by charge nurse that the
medications were not available and waiting for pharmacy to deliver.
Residents Affected - Few
During on observation of medication cart (storage, secure, reliable and transport of medications to
residents) 1 along with license vocational nurse A (LVN A) on 8/14/2024 at 12:15 p.m., for physician
ordered medications supply for Resident 2, LVN A confirmed there was no supply of potassium chloride
and tirzepatide in medication cart 1 or in medication supply room (drug preparation and storage room). LVN
A also confirmed medication rosuvastatin 10 mg, 4 doses were given from supply of 15 tablets received
from pharmacy since Resident 2 admitted on [DATE].
During an interview with LVN A on 8/14/2024 at 12:25 p.m., the RN A reviewed EMAR for Resident 2,
acknowledged EMAR documentation of 9 means medications not administered. RN A confirmed potassium
chloride, and tirzepatide were not given to Resident due to medications were not available to administer.
RN A also confirmed Resident 2 received rosuvastatin 4 doses only based on tablets taken to administered
from supply not administered 6 does as documented in EMAR. RN A stated license staff should have called
pharmacy when medications were not available to administer to Resident 2. RN A also stated Resident 2
should have received medications as ordered. RN A further stated will call pharmacy today for these two
medications.
During an interview with RN A on 8/14/2024 at 12:35 p.m., RN A reviewed Resident 1' EMAR for June
2024, acknowledged medication quetiapine 25 mg was not administered for above dates due to
unavailability of medication. RN A stated license nurses should have followed up with pharmacy for supply
of quetiapine, received medication from pharmacy and administered to Resident 1 as ordered by MD.
During an interview with facility's director nursing on 8/14/2024 at 12:58 p.m. DON confirmed Residents 1
and 2 did not receive medications as ordered. DON stated license staff should have followed up with
pharmacy when medications were not available, received supply of medications and administered to
Resident 1 and 2 as ordered by MD without missing doses of medications. DON also stated license staff
should not have documented as administered medication rosuvastatin without giving to Resident 2.
Review of facility's P&P titled, Administering Medications, revised April 2019, the P&P indicated,
Medications are administered in according with prescriber orders, including nay required time frame. The
individual administering the medication must initial the resident's MAR (medication administration record)
on the appropriate line after giving each medication and before administering the next ones.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055356
If continuation sheet
Page 4 of 4